stockrow
Friday 6 November 2026
Export BCPC’s income statement to Excel — free account
Balchem Corporation
BCPC Basic Materials Specialty Chemicals
Balchem Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 8.75% from fiscal 2024.
- Revenue
- +8.63%
- EPS
- +17.7%
- Free cash flow
- +14.4%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
175.54
4.17
−2.32%
Follow BCPC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
31.07 | 33.19 | 34.80 | 32.29 |
+8 more quarters Free account |
P/S ratio |
4.71 | 4.96 | 5.12 | 4.77 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
74.94 | 115.39 | 135.11 | 73.55 | |
P/B ratio |
3.94 | 4.14 | 4.21 | 3.94 | |
Price to Tangible BV |
10.63 | 11.57 | 12.17 | 12.05 | |
EV/Sales |
4.82 | 5.10 | 5.27 | 4.91 | |
EV/EBITDA |
19.20 | 20.53 | 21.32 | 19.98 | |
EV/Operating CF |
23.88 | 25.22 | 25.29 | 23.53 | |
EV/FCF |
(45.40) | (44.44) | (46.50) | (41.55) | |
Quick Ratio |
1.29 | 1.46 | 1.49 | 1.24 | |
Current Ratio |
2.47 | 2.66 | 2.55 | 2.07 | |
Net Debt/EBITDA |
1.08 | 1.58 | 1.75 | 1.76 | |
Debt/Assets |
8.65% | 10.43% | 11.34% | 11.09% | |
Debt/Equity |
0.11 | 0.14 | 0.15 | 0.15 | |
Asset Turnover |
0.66 | 0.65 | 0.64 | 0.64 | |
Operating CF/Net income |
1.49 | 1.05 | 0.99 | 1.72 | |
Capex/Depreciation |
(1.01) | (0.89) | (0.50) | (1.36) | |
Interest Coverage |
32.28 | 30.56 | 25.14 | 27.52 | |
Research and Development Expense of Revenue |
1.84% | 1.60% | 2.17% | 1.92% | |
Selling, General and Administrative Expense of Revenue |
13.05% | 14.06% | 14.62% | 13.87% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.50 | 0.50 | |
Share Based Compensation of Revenue |
1.73% | 2.08% | 1.98% | 1.43% | |
Graham Net Nets |
0.01 | 0.00 | 0.00 | (0.01) | |
Graham Number |
70.72 | 68.38 | 66.40 | 64.54 | |
Earnings Yield |
3.22% | 3.01% | 2.87% | 3.10% | |
Free Cash Flow Yield |
(2.25%) | (2.31%) | (2.21%) | (2.48%) | |
Revenue per Share |
9.17 | 8.90 | 8.48 | 8.17 | |
Operating CF per Share |
2.20 | 1.46 | 1.25 | 2.09 | |
Capex per Share |
(0.39) | (0.34) | (0.20) | (0.49) | |
Free Cash Flow per Share |
1.81 | 1.12 | 1.06 | 1.59 | |
Cash per Share |
2.09 | 1.98 | 2.28 | 2.31 | |
Shareholders Equity per Share |
41.86 | 40.82 | 40.24 | 38.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
41.86 | 40.82 | 40.24 | 38.97 | |
Free Cash Flow |
57.30 | 35.83 | 33.81 | 51.34 | |
Working Capital |
240.76 | 242.67 | 236.40 | 189.23 | |
Capital Expenditures |
(12.47) | (10.88) | (6.25) | (15.94) | |
Net Current Asset Value |
28.08 | 3.80 | (19.68) | (63.22) | |
EV/EBIT |
23.28 | 24.98 | 26.02 | 24.34 | |
Capex to Sales |
0.04 | 0.04 | 0.02 | 0.06 | |
Price to Operating Income |
22.77 | 24.31 | 25.30 | 23.64 | |
| Other line items | |||||
Average Receivables |
138.59 | 142.48 | 142.34 | 131.63 | |
Average Payables |
59.51 | 69.16 | 68.35 | 57.59 | |
Average Inventory |
154.72 | 154.85 | 145.83 | 131.13 | |
Average Assets |
1,682.30 | 1,682.63 | 1,655.65 | 1,630.81 | |
Average Common Equity |
1,312.32 | 1,285.15 | 1,246.91 | 1,203.66 |
Columns are period end dates · fundamentals updated 2 Nov 2026